Editor

Lee, Daniel W.

Shah, Nirali N.

Place of Publication

Cambridge, MA

Publisher

Elsevier, Inc.

Publication Date

2020

Physical Description

xiv, 229 p. : ill. ; 24 cm.

Subjects

Neoplasms - therapy

Receptors, Chimeric Antigen - therapeutic use

Receptors, Antigen, T-Cell

Immunotherapy, Adoptive - methods

Cell- and Tissue-Based Therapy

Abstract

Contents:

Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients receiving CAR therapy -- Neurotoxicities after CAR-T cell immunotherapy -- Hematologic and non-CRS toxicities -- Response assessment and post-CAR-T cell therapy management -- Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy -- Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas -- CAR T cell therapy for CNS malignancies -- CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.

ISBN

9780323661812

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Abbotsford Library

Victoria Library

Call Number

QZ266 C538 2020

Copies

Author

Buka Richard J.

Moloney, Deidre

Place of Publication

Abingdon, UK

Publisher

S. Karger Publishers Ltd.

Publication Date

2021

Series

Proquest Ebook Central

Fast facts (UK)

Subjects

Lymphoma, Large B-Cell, Diffuse - therapy

Lymphoma, Large B-Cell, Diffuse - nursing

Neoplasms - therapy

Receptors, Chimeric Antigen - therapeutic use

Receptors, Antigen, T-Cell

Immunotherapy, Adoptive - methods

Cell- and Tissue-Based Therapy

Oncology Nursing

ISBN

9783318069358

9783318070248

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer network computer. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Ghobadi, Armin

DiPersio, John F.

Edition

1st ed.

Place of Publication

Cham, Switzerland

Publisher

Humana Press

Publication Date

c2022

Series

Proquest Ebook Central

Subjects

Immunotherapy, Adoptive

Lymphoma

Leukemia

Lymphocytes, Tumor-Infiltrating

Abstract

"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia (ALL). These advances have dramatically improved the management of patients with relapsed refractory lymphoma, myeloma and leukemia. Gene and Cellular Immunotherapy for Cancer offers readers a comprehensive review of current cellular and gene-based immunotherapies. Divided into eighteen cohesive chapters, this book provides an in-depth and detailed look into cellular-based immunotherapies including CAR-T, TCR-T, TIL, Viral CTLs, NK cells in addition to T/NK cell engagers, focusing on their historical perspectives, biology, development and manufacturing, toxicities and more.

Edited by two leading experts on gene and cellular immunotherapy, the book will feature chapters written by a diverse collection of recognized and up-and-coming experts and researchers in the field, providing oncologists, immunologists, researchers and clinical and basic science trainees with a bench to bedside view of the latest developments in the field." --publisher

ISBN

9783030878481

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Alternate Title

National Comprehensive Cancer Network guidelines for patients : immunotherapy side effects: CAR T-cell therapy

Corporate Author

National Comprehensive Cancer Network (NCCN)

Place of Publication

Plymouth Meeting, PA

Publisher

National Comprehensive Cancer Network

Publication Date

2022

Physical Description

32 p. : col. ill. ; 29 cm

Series

NCCN guidelines for patients

Subjects

Popular Work

Immunotherapy, Adoptive - adverse effects

Immunotherapy - adverse effects

ISBN

9781954190627

Language

English

Material Type

Book

Online

Audience

Patient or Public

Location

Internet

Abbotsford Cancer Info Ctr

Kelowna Cancer Info Ctr

Victoria Cancer Info Ctr

Vancouver Library

Call Number

QZ267 N277c 2022

Copies